78
Growth Score in past quarter
pts
Heat Score 78 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
206302
HumGel is a biotechnology company that develops human tumor-derived extracellular matrix products for cancer research.
About the Company
HumGel is a biotechnology company that develops human tumor-derived extracellular matrix products for cancer research. Its main product, MyoGel, provides an alternative to animal-derived matrices, replicating the human tumor microenvironment for studies on cell invasion, migration, metastasis, and drug testing. The company focuses on creating
in-vitro cancer models that are predictive, automation-friendly, and ethically sourced for researchers and pharmaceutical developers.
Women Founded
Women Led